|
Local Standard of Care Clinical Trials
2 actively recruiting trials
Also known as: Bevacizumab, Everolimus, Hydroxycarbamide, No active treatment (observation with regular follow-up and best supportive care), Octreotide (Sandostatin LAR), Sunitinib
Other2 trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.